Richard Schwartz | Immunology | Innovative Research Award

Innovative Research Award

         Researcher Information
Researcher Richard Schwartz
Affiliation Michigan State University
Country United States
Scopus ID 7404170129
Documents 56
Citations 1,968
h-index 27
Subject Area Immunology
Event International Molecular Biologist Awards
ORCID 0000-0003-3151-2511
Google Scholar QBELV48AAAAJ

Richard Schwartz

Michigan State University, United States

Richard Schwartz has developed an academic profile in Immunology through peer-reviewed publications, collaborative investigations, and measurable bibliometric impact. His scholarly activities demonstrate continued engagement with immunological research and interdisciplinary scientific inquiry, supporting recognition within international academic communities. The Innovative Research Award recognizes distinguished scientific achievement, sustained scholarly productivity, and meaningful contributions to research advancement. [1]

Abstract

Richard Schwartz is an academic researcher whose work in immunology has contributed to scientific understanding through peer-reviewed publications, interdisciplinary collaboration, and sustained research activity. His publication record, citation performance, and internationally indexed research output reflect continuing influence within the biomedical research community. The academic indicators summarized in this profile provide an overview of his scholarly contributions using publicly available bibliometric information.[1][2]

Keywords

Immunology, Biomedical Research, Immune Response, Scientific Publications, Research Impact, Citation Analysis, Molecular Biology, Academic Excellence.

Introduction

Recognition of scientific achievement commonly incorporates qualitative assessment together with bibliometric indicators such as publication output, citation performance, and the h-index. These measures assist academic institutions and professional organizations in evaluating the influence and continuity of scholarly research while considering broader scientific contributions.[3]

Research Profile

  • Affiliated with Michigan State University.
  • Primary research specialization in Immunology.
  • Author of 56 scholarly publications indexed in Scopus.
  • Research has received 1,968 citations with an h-index of 27.
  • Active participant in collaborative biomedical and immunological research.

Research Contributions

Richard Schwartz has contributed to immunology through investigations that enhance understanding of immune regulation, disease mechanisms, and biomedical applications. His research emphasizes rigorous experimental methodologies, scientific collaboration, and dissemination of findings through internationally recognized journals. These contributions have supported continued progress within immunological science and related biomedical disciplines.[2][4]

Publications

  • Peer-reviewed research articles in immunology and biomedical sciences.
  • Internationally indexed publications demonstrating sustained scientific productivity.
  • Research cited by scholars across multiple areas of biological and medical sciences.

Research Impact

The available bibliometric indicators demonstrate continued scholarly influence through publication productivity, citation performance, and recognized research visibility. Citation metrics provide quantitative evidence of scientific engagement and complement qualitative assessment of research significance within the academic community.[1][5]

Award Suitability

Based on publicly available academic indicators, Richard Schwartz demonstrates characteristics commonly associated with recognition for scientific innovation, including sustained publication activity, measurable citation impact, and contributions to immunology. Such achievements provide evidence supporting consideration for recognition within the International Molecular Biologist Awards while remaining subject to independent review and evaluation criteria.[3]

Conclusion

Richard Schwartz has established a scholarly profile characterized by consistent research productivity, internationally indexed publications, and measurable academic impact. His work in immunology contributes to the advancement of biomedical knowledge and reflects continued commitment to scientific excellence, collaboration, and responsible dissemination of research findings.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Richard Schwartz, Author ID 7404170129. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7404170129
  2. Google Scholar. (n.d.). Richard Schwartz – Google Scholar Citations.
    https://scholar.google.co.uk/citations?user=QBELV48AAAAJ&hl=en&oi=ao
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
    https://doi.org/10.1073/pnas.0507655102
  4. Orcid. Author details .Advances in immunological research and translational science.
    https://doi.org/10.1038/nri.2017.123
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Manuela Cappelletti | Immunology | Industry Impact Award

Mrs. Manuela Cappelletti | Immunology | Industry Impact Award 

Senior lab biologist | TAKIS srl | Italy

Mrs. Manuela Cappelletti is an accomplished Italian Senior Laboratory Biologist with extensive experience in molecular biology, immunology, and preclinical biotechnology. She has played a key role at Takis Srl in Rome, contributing to research in monoclonal antibody generation and vaccine development. Previously, she held senior research positions at IRBM Merck Research Laboratories and RTC Research Toxicology Center, where she developed expertise in molecular cloning, cell biology, and animal experimentation. At Takis, she oversees hybridoma generation, antibody subcloning, and large-scale antibody production, ensuring high standards of biosafety and reproducibility. Her work has advanced innovative immunotherapy and vaccine platforms, including contributions to DNA-based vaccine research. With 23 scientific publications, 1,724 citations by 1,545 documents, and an h-index of 18, her research has significantly impacted the fields of antibody science and translational immunology. Renowned for her precision and leadership in laboratory innovation, Manuela continues to bridge fundamental science with applied biomedical research, fostering progress in immunotherapy and infectious disease solutions.

Profile: Scopus | ORCID

Featured Publications

Cappelletti, M., et al. (n.d.). Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein. Antibodies (Basel). Cited by 12.

Cappelletti, M., et al. (n.d.). COVID-eVax: An electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD. Molecular Therapy, 30(4). Cited by 58.

Cappelletti, M., et al. (n.d.). COVID-eVax DNA vaccine elicits protective immune responses in animal models. bioRxiv. Cited by 72.

Cappelletti, M., et al. (n.d.). Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA. Journal of Gene Medicine, 5(3). Cited by 130.

Cappelletti, M., et al. (n.d.). C/EBP beta and acute phase gene regulation in liver cells. Cell Death and Differentiation, 3(2). Cited by 45.